HR Execs on the Move

Icosavax

www.icosavax.com

 
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.icosavax.com
  • 1616 Eastlake Avenue East Suite 208
    Seattle, WA USA 98102
  • Phone: 206.737.0085

Executives

Name Title Contact Details
Tara Hayward
Senior Director, RandD Partnerships Profile
Thomas Russo
Chief Financial Officer Profile
Adam Simpson
Co Founder and Chief Executive Officer Profile

Similar Companies

Fog Pharmaceuticals

FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered `undruggable`.

InterVenn Biosciences

Clinical Glycoproteomics + Artificial Intelligence

Leap Therapeutics

Leap is developing novel drugs to change the practice of cancer medicine

Inspirion Biosciences

Inspirion Biosciences protects the advancement of science, the safety and security of researchers, and the health of surrounding communities through integrated solutions in risk strategy. Learn more here.

Noxilizer

Noxilizer, Inc. provides room-temperature nitrogen dioxide sterilization technology that offers many benefits over traditional sterilization methods. Noxilizer sells sterilization equipment to pharmaceutical, biotech and medical device manufacturers and also offers contract sterilization services at its Baltimore, MD facilities. Noxilizer’s expert microbiology and material compatibility team is ready to partner to solve sterilization challenges through every phase of the process. Noxilizer, Inc., founded in 2004, is privately held with offices in the US, United Kingdom, and Japan.